查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1866941

足下垂植入市场按类型、应用和最终用户划分 - 全球预测 2025-2032

Foot Drop Implants Market by Type, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，足下垂植入市场将成长至 73.4 亿美元，复合年增长率为 6.69%。

关键市场统计数据
基准年 2024 43.7亿美元
预计年份：2025年 46.6亿美元
预测年份 2032 73.4亿美元
复合年增长率 (%) 6.69%

对临床需求、技术进步和治疗重点进行综合概述，这些因素共同塑造了现代持久性足下垂矫正方法。

足下垂仍然是神经科、整形外科和復健科领域持续存在的临床挑战，而植入式解决方案的进步正在重塑治疗路径。背屈无力的患者面临活动能力下降、跌倒风险增加以及生活品质的一系列负面影响，因此临床治疗的重点在于恢復功能，而不仅仅是补偿功能障碍。过去十年，微创技术、精密的外科手术以及改进的神经刺激设备的融合，为持续的功能恢復创造了新的选择。

临床医生和设备研发人员正在努力解决一个公认的治疗缺口。许多保守治疗方法只能提供暂时缓解，但不足以达到长期功能恢復；而传统的外科手术方法创伤性大，且术后復健负担沉重。在这些情况下，植入式神经刺激设备和肌腱转移植入因其能够提供持续的背屈支撑，同时减少日常管理需求，而备受临床关注。更重要的是，植入式脉衝产生器、电池技术和电极材料的不断改进，使得植入式设备尺寸更小、刺激更灵敏，并可根据个体步态模式进行客製化。

因此，临床实践、研发和医疗设备开发领域的相关人员正在重新调整优先事项，转向整合植入性能、復健通讯协定和远端监测的解决方案。本文为深入分析技术成熟度、临床路径和医疗保健系统动态如何共同影响足下垂植入领域的采用趋势和投资决策奠定了基础。

技术小型化、数位化整合和不断发展的临床证据如何重新定义足下垂植入的竞争格局和应用路径

足下垂植入正经历一场变革，其驱动力包括技术小型化、新型刺激模式以及个人化復健通讯协定日益增长的重要性。植入式脉衝产生器架构和电极设计的创新，以及精湛的外科手术技术，正在降低手术的复杂性，并扩大以往仅依赖矫正器具的患者群体。同时，包括穿戴式步态分析和远距復健平台在内的数位健康整合，实现了对治疗效果的持续监测，支援设备的迭代优化，并能快速识别无反应者。

伴随这些变化而来的是日益成熟的临床证据基础。前瞻性队列研究和器械註册登记正开始提供更一致的功能性结果指标。因此，支付者和采购人员开始评估短期改善以外的价值，并优先考虑那些能够持续改善活动能力并减少后续护理需求的干预措施。监管路径也随着神经刺激技术的创新而不断发展，明确了对安全性、生物相容性和长期性能指标的预期，从而降低了开发人员和投资者的不确定性。

此外，该行业正经历竞争格局的重组，成熟的神经调控设备製造商在其产品组合中增加了专门针对足下垂的植入，而专注于特定临床领域和新型刺激方式的Start-Ups则致力于开发新的刺激模式。这些协同因素正在加速从保守治疗到主动器材辅助的背屈功能恢復的转变，并为外科医生、復健医师、工程师和医疗系统领导者之间的跨学科合作创造了新的机会。

评估关税变化对供应链带来的压力，并考虑采取策略性应对措施，以增强足下垂植入价值链的製造韧性、采购时机和定价机制。

美国关税调整的累积影响正对足下垂植入生态系统产生多方面衝击，影响供应链策略、零件采购和商业性定价，但并未改变这些先进干预措施的临床原理。关税相关的成本压力对依赖进口专用材料和子组件的设备零件尤其显着，促使製造商重新评估其筹资策略，并透过近岸外包和选择替代供应商来降低风险。由于决策者希望确保整体拥有成本和维护成本的确定性，这可能会导致医院和復健中心的采购週期延长。

为应对这些压力，製造商正透过重新评估材料清单、优化生产布局以及更加重视可製造性设计，来降低对受关税影响零件的依赖。此外，他们越来越重视弹性价格设定模式和基本契约的日益复杂也推动了某些领域的垂直整合，尤其是在特殊脉衝产生器和电极系统领域，因为在这些领域，零件的可追溯性对临床安全至关重要。

整体而言，关税对营运构成不利影响，促使策略重点转向供应链韧性、製造多元化以及强调可证实的临床效益的商业结构。对相关人员而言，实际意义在于需要将关税情境规划纳入采购和产品开发蓝图，以确保能够持续获得先进的足下垂治疗方案，并保障临床服务的连续性。

深度細項分析揭示了设备分类、临床应用和细粒度的最终用户路径如何决定其采纳、证据需求和商业化策略。

详细的市场区隔分析揭示了治疗需求、设备架构和护理环境如何相互作用，从而影响足下垂植入的商业性和临床策略。按类型划分，市场分为神经刺激设备植入和肌腱移植植入。神经刺激设备又细分为植入式脉衝产生器和神经电极，其中植入式脉衝产生器又分为不可充电式和可充电式。肌腱移植植入也类似地分为同种异体移植和自体移植。这种细分錶明，耐用性、可充电性和电极介面设计之间的技术权衡直接影响患者选择和手术流程。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 用于个人化步态矫正的封闭回路型神经刺激系统取得进展
  • 提高足下垂植入中无线充电和遥测技术的整合度
  • 开发用于植入功能性电刺激装置的微创手术技术
  • 人工智慧驱动的步态分析平台的出现，为优化植入程式设计提供了可能。
  • 重点研究发生物相容性电极材料，以提高植入的长期耐久性。
  • 机器人辅助復健与植入式功能刺激装置的整合
  • 神经调控植入监管核准和报销框架的演变
  • 利用3D列印技术，透过针对患者特异性的植入设计，提升解剖结构的贴合度。
  • 医疗设备製造商与软体公司合作，拓展远端监控能力
  • 穿戴式电疗设备的应用日益普及，以补充植入式解决方案。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：足下垂植入市场（按类型划分）

  • 神经刺激设备植入
    • 植入式脉衝产生器
      • 不可充电发电机
      • 可充电发电机
    • 神经电极
  • 肌腱转移植入
    • 同种异体移植
    • 自体移植

9. 按应用分類的足下垂植入市场

  • 足部麻痹
  • 多发性硬化症
  • 中风后康復
    • 急性中风后
    • 慢性中风后遗症
  • 创伤性神经损伤

第十章 依最终用户分類的足下垂植入市场

  • 医院
    • 私立医院
    • 公立医院
  • 復健中心
    • 住院復健
    • 门诊復健
  • 专科诊所

第十一章：足下垂植入市场区域划分

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十二章：足下垂植入市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十三章 各国足下垂植入市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十四章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Ottobock SE & Co. KGaA
    • Bioness, Inc.
    • Innovative Neurotronics, Inc.
    • Ossur hf.
    • NeuroMetrix, Inc.
    • AxioBionics, LLC
    • Stimwave Technologies, Inc.
Product Code: MRR-CD5A9334D49B

The Foot Drop Implants Market is projected to grow by USD 7.34 billion at a CAGR of 6.69% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.37 billion
Estimated Year [2025] USD 4.66 billion
Forecast Year [2032] USD 7.34 billion
CAGR (%) 6.69%

An integrative overview of clinical needs, technological evolution, and therapeutic priorities shaping modern approaches to durable foot drop correction

Foot drop represents a persistent clinical challenge that spans neurology, orthopedics, and rehabilitation disciplines, and advances in implantable solutions are reshaping therapeutic pathways. Patients experiencing dorsiflexion weakness encounter reduced mobility, increased fall risk, and cascading impacts on quality of life, which has focused clinical attention on interventions that restore function rather than merely compensating for deficits. Over the past decade, minimally invasive techniques, refined surgical approaches, and improvements in neurostimulation hardware have converged to create new options for durable functional restoration.

Clinicians and device developers are responding to clearly identified therapy gaps: many conservative measures provide temporary benefit but insufficient long-term functional recovery, while older surgical techniques can be invasive and carry extended rehabilitation burdens. In this context, implantable nerve stimulators and tendon transfer implants are drawing clinical interest for their potential to deliver consistent dorsiflexion support with fewer daily management requirements. Importantly, ongoing iterations in implantable pulse generators, battery technology, and electrode materials are enabling smaller form factors and more nuanced stimulation profiles, which can be tuned to individual gait patterns.

As a result, stakeholders across clinical practice, research, and medical device development are recalibrating priorities toward integrated solutions that couple implant performance with rehabilitation protocols and remote monitoring. This introduction sets the stage for a deeper analysis of how technological maturity, clinical pathways, and health system dynamics combine to influence adoption trends and investment decisions in the foot drop implant space.

How technological miniaturization, digital integration, and evolving clinical evidence are collectively redefining competitive dynamics and adoption pathways for foot drop implants

The landscape for foot drop implants is undergoing transformative shifts driven by technological miniaturization, novel stimulation paradigms, and an increased emphasis on personalized rehabilitation protocols. Innovations in implantable pulse generator architecture and electrode design, coupled with refined surgical techniques, are reducing procedural complexity and expanding candidacy among patients who previously relied solely on orthotic devices. At the same time, digital health integration - including wearable gait analytics and tele-rehabilitation platforms - is enabling continuous outcome monitoring, which supports iterative device optimization and more rapid identification of non-responders.

These changes are accompanied by a maturation of clinical evidence, where prospective cohort studies and device registries are starting to deliver more consistent functional outcome metrics. Consequently, payers and procurement leaders are beginning to assess value beyond short-term improvements, prioritizing interventions that demonstrate durable gains in mobility and reduced downstream care needs. Regulatory pathways are also evolving to accommodate neurostimulation innovations, with clearer expectations around safety, biocompatibility, and long-term performance metrics, which reduces uncertainty for developers and investors.

Furthermore, the industry is witnessing a reconfiguration of competitive dynamics: established neuromodulation device manufacturers are enhancing portfolios to include foot drop-specific implants, while specialized startups are pursuing focused clinical niches and novel stimulation modalities. These converging drivers are accelerating a transition from conservative management toward active, device-mediated restoration of dorsiflexion, and are creating new opportunities for cross-disciplinary collaboration among surgeons, physiatrists, engineers, and health system leaders.

Assessing tariff-driven supply chain pressures and strategic responses that shape manufacturing resilience, procurement timing, and pricing mechanisms across the foot drop implant value chain

The cumulative effect of tariff shifts in the United States on the foot drop implant ecosystem is multifaceted, influencing supply chain strategies, component sourcing, and commercial pricing without altering the clinical rationale for advanced interventions. Tariff-related cost pressures tend to be most acute for device components that rely on specialized imported materials or subassemblies, prompting manufacturers to reassess sourcing strategies and to explore nearshoring or alternative supplier qualification to mitigate exposure. In turn, procurement cycles at hospitals and rehabilitation centers may lengthen as decision-makers seek greater certainty on total cost of ownership and maintenance expenses.

Manufacturers are responding to these pressures by reexamining bill-of-materials, optimizing production footprints, and increasing emphasis on design for manufacturability to reduce dependency on tariff-exposed inputs. Additionally, companies are placing greater importance on flexible pricing models and value-based contracting that align payment with demonstrated functional improvements, thereby insulating providers from price volatility. Regulatory compliance and customs complexity are also encouraging greater vertical integration in certain segments, particularly for specialized pulse generators and electrode systems where component traceability is critical for clinical safety.

Overall, tariffs introduce an operational headwind that shifts strategic focus toward supply chain resilience, diversified manufacturing, and commercial structures that emphasize demonstrable clinical benefit. For stakeholders, the practical implication is a need to incorporate tariff scenario planning within procurement and product development roadmaps to maintain predictable access to advanced foot drop interventions and to preserve continuity in clinical services.

Deep segmentation analysis revealing how device typologies, clinical applications, and nuanced end-user pathways determine adoption, evidence needs, and commercialization strategies

A nuanced read of segmentation reveals how therapeutic needs, device architecture, and care settings interplay to shape commercial and clinical strategy for foot drop implants. Based on Type, the market is examined across nerve stimulator implants and tendon transfer implants, with nerve stimulators further differentiated into implantable pulse generators and nerve electrodes, and implantable pulse generators further dissected into non-rechargeable and rechargeable generator options; tendon transfer implants are similarly parsed into allograft transfers and autograft transfers. This granularity highlights that engineering trade-offs between longevity, rechargeability, and electrode interface design directly influence patient selection and surgical workflow.

Based on Application, the portfolio of use cases spans foot palsy, multiple sclerosis, post stroke rehabilitation, and traumatic nerve injury, with post stroke rehabilitation further distinguished into acute post stroke and chronic post stroke scenarios. Clinical pathways differ substantially across these applications: acute post stroke interventions prioritize early functional recovery and integration with inpatient rehabilitation, while chronic post stroke and neurodegenerative conditions emphasize long-term management and device programmability. These distinctions drive divergent evidence requirements, where acute settings often necessitate rapid outcome readouts, and chronic conditions require longitudinal performance data to justify continued device use.

Based on End User, adoption patterns vary among hospitals, rehabilitation centers, and specialty clinics, with hospitals parsed into private and public institutions and rehabilitation centers separated into inpatient and outpatient modalities. Hospital-based adoption is influenced by procedural volume, surgical expertise, and capital planning cycles, whereas rehabilitation centers weigh integration with therapy programs and ease of device tuning. Specialty clinics often act as early adopters focused on niche protocols. Understanding this layered segmentation enables stakeholders to align clinical trials, reimbursement strategies, and go-to-market activities with the distinct needs and operational realities of each segment.

How regional regulatory diversity, reimbursement expectations, and clinical infrastructure shape differentiated commercialization pathways for foot drop implant technologies

Regional dynamics exert a decisive influence on regulatory interpretation, clinical practice variability, and supply chain logistics for foot drop implants. In the Americas, clinical adoption has been shaped by a mix of advanced neuromodulation centers, integrated healthcare systems, and a concentrated set of referral pathways that facilitate device testing within multidisciplinary teams. Reimbursement frameworks and hospital procurement processes in this region tend to emphasize demonstrable functional outcomes and cost-consequence narratives, which in turn shapes evidence generation and post-market surveillance strategies.

In Europe, Middle East & Africa, regulatory diversity and heterogeneous payer structures create both opportunities and challenges for manufacturers; high-performing centers in metropolitan areas often act as hubs for early clinical adoption and device refinement, while broader geographic variability demands flexible distribution and training models. Stakeholders operating in this region frequently adopt centralized regulatory strategies combined with localized clinical education to ensure consistent surgical standards and patient follow-up.

In the Asia-Pacific region, the growth of specialized rehabilitation infrastructure, investments in medical technology manufacturing, and a growing emphasis on outcomes-based care are driving interest in implantable interventions. However, differing regulatory timelines, surgical training availability, and variable hospital procurement mechanisms require manufacturers to calibrate market entry plans carefully. Across all regions, successful commercialization depends on tailored clinical evidence packages, robust training programs for surgical and rehabilitation teams, and adaptable supply chain arrangements that respect regional regulatory and reimbursement nuances.

Competitive landscape dynamics driven by platform modularity, clinical partnerships, and real-world evidence strategies that determine differentiation and long-term market viability

Competitive dynamics in the foot drop implant space reflect a combination of established neuromodulation expertise and focused clinical innovators, producing an ecosystem where strategic partnerships and platform extensibility matter as much as device performance. Leading device developers prioritize modular architectures that support both implantable pulse generators and electrode interfaces, enabling rapid iteration and clinical customization while maintaining a common software and service layer for programming and remote monitoring. This modular approach reduces time-to-market for incremental improvements and facilitates managed care conversations around long-term outcomes and service contracts.

At the same time, specialized clinical innovators concentrate on surgical technique optimization and patient phenotyping to demonstrate superior functional outcomes in targeted cohorts, partnering with rehabilitation providers to integrate stimulation protocols into comprehensive care pathways. Supply chain partners and contract manufacturers that can deliver medical-grade components with high traceability are increasingly strategic, particularly where regulatory expectations include rigorous long-term safety documentation. Across the competitive landscape, successful companies invest in evidence generation through registries and real-world data collection, and they build scalable training programs to lower the barrier to clinical adoption.

Finally, collaborations between device manufacturers, rehabilitation technology firms, and digital health platforms are becoming a competitive differentiator, as integration of wearable gait analytics and clinician dashboards enables continuous therapeutic tuning and supports value-based contracting conversations with providers and payers. For investors and corporate strategists, the interplay between platform flexibility, clinical partnerships, and data-driven care models will determine long-term viability and differentiation.

Actionable strategic priorities for product design, evidence generation, supply chain resilience, clinician training, and outcomes-based commercial models to accelerate adoption

Industry leaders seeking to accelerate adoption and commercial success for foot drop implants should align product development with clear clinical workflows and payer expectations while strengthening supply chain resilience. Prioritize device designs that balance rechargeability and longevity with surgical simplicity, and ensure electrode interfaces support adjustable stimulation profiles that can be personalized to patient gait. Concurrently, invest in pragmatic clinical studies and real-world registries that capture meaningful functional outcomes across acute and chronic care settings to support reimbursement discussions and hospital procurement committees.

Operationally, manufacturers should pursue supplier diversification and consider nearshoring critical component production where tariff exposure or customs complexity presents material risk. Develop comprehensive training and certification programs for surgeons and rehabilitation clinicians to reduce variability in implantation and programming, and build integrated care pathways that align implant intervention with targeted therapy regimens to maximize functional gains. Moreover, establish partnerships with digital health providers to incorporate wearable gait analytics and remote monitoring into product offerings, thereby creating differentiated services that support outcomes-based contracting.

From a commercial standpoint, tailor market entry approaches by region and end-user type, emphasizing solutions that demonstrate clear operational benefits in the specific care setting, whether that is inpatient stroke units, outpatient rehab clinics, or specialty centers. Finally, maintain a flexible pricing architecture that can accommodate device lifecycle models, service subscriptions, and bundled care agreements to meet the diverse financial constraints of private and public health systems.

A transparent multi-method research approach combining clinician interviews, regulatory review, literature synthesis, and supply chain scenario analysis to validate findings and recommendations

The research underpinning this analysis combined a multi-method approach designed to integrate clinical, regulatory, and commercial perspectives while ensuring transparency and reproducibility. Primary inputs included structured interviews with surgeons, physiatrists, rehabilitation therapists, and procurement leaders, along with consultations with device engineers and quality/regulatory experts to validate technical feasibility and safety considerations. Secondary inputs comprised peer-reviewed clinical literature, device-specific regulatory filings, standards documentation on implantable neuromodulation safety, and public clinical trial registries to corroborate outcome measures and study designs.

Data synthesis involved cross-validation of qualitative insights against documented clinical outcomes and regulatory frameworks, with an emphasis on triangulating evidence where limited randomized data exists. The methodology also incorporated scenario analysis for supply chain and tariff impacts, mapping dependencies across bill-of-materials, manufacturing geographies, and distribution channels to surface operational vulnerabilities and viable mitigation strategies. Peer review of the findings was conducted by external clinical advisors to ensure clinical plausibility and to refine recommendations related to care pathways and training requirements.

All sources were cataloged and assessed for methodological rigor and relevance, and where gaps were identified, targeted primary interviews were executed to fill critical knowledge voids. This approach produced a consolidated, practice-oriented perspective on the technology, clinical adoption barriers, and commercial levers that inform the strategic guidance presented in the report.

A conclusive synthesis emphasizing the clinical promise, operational imperatives, and cross-disciplinary actions required to convert technological advances into durable patient mobility improvements

In conclusion, foot drop implants represent a maturing intersection of neuromodulation engineering, surgical innovation, and rehabilitation science that collectively offers the potential to transform mobility outcomes for patients with diverse neurologic etiologies. The trajectory of the field is shaped by technology choices around pulse generator architecture and electrode design, the quality and scope of clinical evidence across acute and chronic applications, and pragmatic considerations tied to regional regulatory and reimbursement environments. Stakeholders who align product design with care pathways, invest in evidence generation, and cultivate durable clinical partnerships will be best positioned to deliver meaningful patient benefit and to navigate commercial complexities.

Operational resilience, including proactive supply chain strategies and flexible commercialization models, will mitigate external headwinds such as tariff-related cost pressures while preserving timely access to advanced devices. Moreover, the integration of digital monitoring and data-driven rehabilitation protocols will increasingly drive differentiation and enable value-based conversations with payers and providers. As the field evolves, a focus on patient-centered outcomes, standardized measurement frameworks, and scalable clinician training will be essential to translate technological promise into measurable improvements in mobility and quality of life.

The cumulative picture is one of cautious optimism: opportunities for clinical impact and commercial growth exist, but realizing them requires coordinated effort across engineering, clinical research, and health system stakeholders to ensure that innovations are both effective and deliverable within real-world care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Advancements in closed loop neurostimulation systems for personalized gait correction
  • 5.2. Increase in wireless charging and telemetry integration for foot drop implants
  • 5.3. Development of minimally invasive surgical techniques for implanting FES devices
  • 5.4. Emergence of AI driven gait analysis platforms for optimized implant programming
  • 5.5. Focus on biocompatible electrode materials to enhance long term implant durability
  • 5.6. Integration of robotics assisted rehabilitation with implanted functional stimulators
  • 5.7. Regulatory approvals and reimbursement frameworks evolving for neuromodulation implants
  • 5.8. Patient specific implant designs using 3D printing for improved anatomical fit
  • 5.9. Collaborations between medtech and software companies to expand remote monitoring capabilities
  • 5.10. Increasing prevalence of wearable electroceutical devices complementing implanted solutions

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Foot Drop Implants Market, by Type

  • 8.1. Nerve Stimulator Implants
    • 8.1.1. Implantable Pulse Generators
      • 8.1.1.1. Non Rechargeable Generators
      • 8.1.1.2. Rechargeable Generators
    • 8.1.2. Nerve Electrodes
  • 8.2. Tendon Transfer Implants
    • 8.2.1. Allograft Transfers
    • 8.2.2. Autograft Transfers

9. Foot Drop Implants Market, by Application

  • 9.1. Foot Palsy
  • 9.2. Multiple Sclerosis
  • 9.3. Post Stroke Rehabilitation
    • 9.3.1. Acute Post Stroke
    • 9.3.2. Chronic Post Stroke
  • 9.4. Traumatic Nerve Injury

10. Foot Drop Implants Market, by End User

  • 10.1. Hospitals
    • 10.1.1. Private Hospitals
    • 10.1.2. Public Hospitals
  • 10.2. Rehabilitation Centers
    • 10.2.1. Inpatient Rehabilitation
    • 10.2.2. Outpatient Rehabilitation
  • 10.3. Specialty Clinics

11. Foot Drop Implants Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Foot Drop Implants Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Foot Drop Implants Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. Ottobock SE & Co. KGaA
    • 14.3.2. Bioness, Inc.
    • 14.3.3. Innovative Neurotronics, Inc.
    • 14.3.4. Ossur hf.
    • 14.3.5. NeuroMetrix, Inc.
    • 14.3.6. AxioBionics, LLC
    • 14.3.7. Stimwave Technologies, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. FOOT DROP IMPLANTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. FOOT DROP IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. FOOT DROP IMPLANTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NON RECHARGEABLE GENERATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NON RECHARGEABLE GENERATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NON RECHARGEABLE GENERATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NON RECHARGEABLE GENERATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NON RECHARGEABLE GENERATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NON RECHARGEABLE GENERATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY RECHARGEABLE GENERATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY RECHARGEABLE GENERATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY RECHARGEABLE GENERATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY RECHARGEABLE GENERATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY RECHARGEABLE GENERATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY RECHARGEABLE GENERATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE ELECTRODES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE ELECTRODES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE ELECTRODES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE ELECTRODES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE ELECTRODES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY NERVE ELECTRODES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY ALLOGRAFT TRANSFERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY ALLOGRAFT TRANSFERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY ALLOGRAFT TRANSFERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY ALLOGRAFT TRANSFERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY ALLOGRAFT TRANSFERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY ALLOGRAFT TRANSFERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY AUTOGRAFT TRANSFERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY AUTOGRAFT TRANSFERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY AUTOGRAFT TRANSFERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY AUTOGRAFT TRANSFERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY AUTOGRAFT TRANSFERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY AUTOGRAFT TRANSFERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY FOOT PALSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY FOOT PALSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY FOOT PALSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY FOOT PALSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY FOOT PALSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY FOOT PALSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY ACUTE POST STROKE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY ACUTE POST STROKE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY ACUTE POST STROKE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY ACUTE POST STROKE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY ACUTE POST STROKE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY ACUTE POST STROKE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY CHRONIC POST STROKE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY CHRONIC POST STROKE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY CHRONIC POST STROKE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY CHRONIC POST STROKE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY CHRONIC POST STROKE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY CHRONIC POST STROKE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TRAUMATIC NERVE INJURY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TRAUMATIC NERVE INJURY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TRAUMATIC NERVE INJURY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TRAUMATIC NERVE INJURY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TRAUMATIC NERVE INJURY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY TRAUMATIC NERVE INJURY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY INPATIENT REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY INPATIENT REHABILITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY INPATIENT REHABILITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY INPATIENT REHABILITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY INPATIENT REHABILITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY INPATIENT REHABILITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY OUTPATIENT REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY OUTPATIENT REHABILITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY OUTPATIENT REHABILITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY OUTPATIENT REHABILITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY OUTPATIENT REHABILITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY OUTPATIENT REHABILITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 256. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2025-2032 (USD MILLION)
  • TABLE 271. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 276. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 277. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2018-2024 (USD MILLION)
  • TABLE 278. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2025-2032 (USD MILLION)
  • TABLE 279. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 280. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 281. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 282. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 283. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 284. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 288. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2025-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2018-2024 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY IMPLANTABLE PULSE GENERATORS, 2025-2032 (USD MILLION)
  • TABLE 299. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 300. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY TENDON TRANSFER IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 301. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY POST STROKE REHABILITATION, 2025-2032 (USD MILLION)
  • TABLE 305. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 306. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 307. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 308. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 309. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2018-2024 (USD MILLION)
  • TABLE 310. ASIA-PACIFIC FOOT DROP IMPLANTS MARKET SIZE, BY REHABILITATION CENTERS, 2025-2032 (USD MILLION)
  • TABLE 311. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 312. GLOBAL FOOT DROP IMPLANTS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 313. ASEAN FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. ASEAN FOOT DROP IMPLANTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. ASEAN FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. ASEAN FOOT DROP IMPLANTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. ASEAN FOOT DROP IMPLANTS MARKET SIZE, BY NERVE STIMULATOR